2000Zhongliu fangzhi yanjiuRequires access

The Significance of p16 Gene Expression in Human Non-small Cell Lung Cancer

Liping Wu, Xie Jin-kui

Open publisher page 0 citations

Abstract

Objective To examine p16 gene expression in human non-small cell lung cancer (NSCLC) and to took for correlations among P16 expression and clinicopathologic features and prognosis.Methods With S P immunohistochemistry method,investigated p16 protein expression in 80 patients with primary NSCLC and 40 with lung benign diseases (as control) with archival paraffin specimens.Results The positive rate of p16 expression in NSCLC and lung benign diseases were 55% (40/80) and 92 5% (37/40),respectively.There was significant difference between the two groups.( P 0 005).The positive rate of p16 expression was related to clinical stage of NSCLC.lower p16 expression in NSCLC was seen with advanced pathological stage of disease.The positive rate of p16 expression in NSCLC had no correlation to its histopathological subtype.Conclusion Immunohistochemical analysis of the p16 gene/MTS 1 products is feasible.These results suggest that p16 /MTS 1 down regulation expression plays an important role in tumorigenesis or tumor progression of NSCLC.Aberrant expression of p16/MTS 1 gene may assess the prognosis in NSCLC.

About this research paper

What this paper is about

Objective To examine p16 gene expression in human non-small cell lung cancer (NSCLC) and to took for correlations among P16 expression and clinicopathologic features and prognosis.Methods With S P immunohistochemistry method,investigated p16 protein expression in 80 patients with primary NSCLC and 40 with lung benign diseases (as control) with archival paraffin specimens.Results The positive rate of p16 expression in NSCLC and lung benign diseases were 55% (40/80) and 92 5% (37/40),respectively.There was significant difference between the two groups.( P 0 005).The positive rate of p16 expression was related to clinical stage of NSCLC.lower p16 expression in NSCLC was seen with advanced pathological stage of disease.The positive rate of p16 expression in NSCLC had no correlation to its histopathological subtype.Conclusion Immunohistochemical analysis of the p16 gene/MTS 1 products is feasible.These results suggest that p16 /MTS 1 down regulation expression plays an important role in tumorigenesis or tumor progression of NSCLC.Aberrant expression of p16/MTS 1 gene may assess the prognosis in NSCLC.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To examine p16 gene expression in human non-small cell lung cancer (NSCLC) and to took for correlations among P16 expression and clinicopathologic features and prognosis.Methods With S P immunohistochemistry method,investigated p16 protein expression in 80 patients with primary NSCLC and 40 with lung benign diseases (as control) with archival paraffin specimens.Results The positive rate of p16 expression in NSCLC and lung benign diseases were 55% (40/80) and 92 5% (37/40),respectively.There was significant difference between the two groups.( P 0 005).The positive rate of p16 expression was related to clinical stage of NSCLC.lower p16 expression in NSCLC was seen with advanced pathological stage of disease.The positive rate of p16 expression in NSCLC had no correlation to its histopathological subtype.Conclusion Immunohistochemical analysis of the p16 gene/MTS 1 products is feasible.These results suggest that p16 /MTS 1 down regulation expression plays an important role in tumorigenesis or tumor progression of NSCLC.Aberrant expression of p16/MTS 1 gene may assess the prognosis in NSCLC.

Key concepts: Immunohistochemistry, Lung cancer, Carcinogenesis, Pathological, Stage (stratigraphy), Lung, Medicine, Carcinoma

Related papers

Back to paper searchBrowse research topicsOriginal source